Nuvectis Pharma
NVCT
NVCT
36 hedge funds and large institutions have $12.8M invested in Nuvectis Pharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
22% less capital invested
Capital invested by funds: $16.5M → $12.8M (-$3.65M)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$353K | |
| 2 | +$284K | |
| 3 | +$237K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$228K |
| 5 |
Renaissance Technologies
New York
|
+$220K |
Top Sellers
| 1 | -$215K | |
| 2 | -$94K | |
| 3 | -$50.1K | |
| 4 |
DWA
Dorsey Wright & Associates
Pasadena,
California
|
-$18K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$3.48K |